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SummAry – Surgical procedure has immense impact on the immune balance. however, little is 
known about perioperative changes in t regulatory and Th17 lymphocyte subpopulations in patients 
undergoing colorectal resection. Patients with resectable colon cancer were enrolled in the study. 
blood samples were obtained on two occasions, i.e. before the procedure and two days after the sur-
gery. We also recruited a control group of young, healthy individuals. lymphocyte subpopulations 
were analyzed with the use of flow cytometry. investigated subpopulations consisted of total lympho-
cyte count, Cd4+, Cd8+, t regulatory foxp3+ (tregs), Th17 lymphocytes and white blood cell 
(WbC) count. There were significant differences in immune cell levels before and after the surgery. 
reduction was recorded in the Cd4+, Cd8+, tregs and total lymphocyte counts (p=0.002, p=0.01, 
p=0.008 and p=0.001, respectively). increase was observed in total WbC and Th17 cells, however, 
Th17 lymphocytes did not reach statistical significance (p=0.01 and p=0.5, respectively). in conclusion, 
surgical intervention caused changes in all lymphocyte subpopulations investigated in patients under-
going surgery for colorectal cancer. however, it seemed to be an effect of perioperative trauma. further 
studies are needed to investigate the impact of surgical intervention on lymphocyte subpopulations.
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Introduction
Colorectal cancer affects 1.4 million people world-
wide, causing 694,000 deaths. novel treatment meth-
ods are improving long-term survival; however, the 
outcomes are still not satisfying. in the vast majority of 
cases, colorectal cancers are treated surgically followed 
by adjuvant therapy, which currently includes usage of 
monoclonal antibodies such as anti-vegf bevaci-
zumab. There is continuing search for optimal therapy 
and currently involves checkpoint immunotherapies. 
Cancer development is accompanied by tissue inflam-
mation. The tumor is infiltrated with different cells of 
the immune system. The composition of immune cells 
in peripheral blood of patients with colorectal cancer is 
under constant investigation1. interaction between dif-
ferent subtypes of immune cells seems to have crucial 
influence on overall survival2. A special role is assigned 
to regulatory lymphocytes with expression of foxp3+ 
molecule (tregs)3. high concentration of tregs in tu-
mor tissue was demonstrated to worsen clinical out-
come in pancreatic and hepatobiliary neoplasms4. Sur-
gical procedure has a huge impact on immune bal-
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ance5,6. however, studies focusing on perioperative 
changes in t regulatory and Th17 lymphocytes sub-
populations are scarce.
The aim of the study was to assess the number of 
lymphocyte subtypes in perioperative period in pa-
tients with colon cancer.
Materials and Methods
Patients with resectable colon cancer were enrolled 
in the study. Patients had to fulfill the following inclu-
sion criteria: age above 18 years, histologically proven 
colon cancer, and resectable lesion. exclusion criteria 
were as follows: patients with distant metastases, pa-
tients with immune deficiencies, patients with colon 
cancer associated with inflammatory bowel disease, 
patients who had been treated with neoadjuvant che-
mo- or radiotherapy, and patients requiring blood 
transfusion during surgical procedure or in the postop-
erative course. The inclusion criteria were met by 14 
patients. blood samples were obtained on two occa-
sions, i.e. before the procedure and two days after the 
surgery. We also recruited control group consisting of 
young, healthy subjects. lymphocyte subpopulations 
were analyzed with the use of flow cytometry.
Isolation of peripheral blood mononuclear cells
Peripheral blood mononuclear cells (PbmC) were 
isolated by standard ficoll-Paque (Pharmacia, uppsa-
la, Sweden) density gradient centrifugation from 
whole peripheral blood samples collected from colo-
rectal cancer patients and healthy control subjects into 
edtA containing tubes (vacutainer System, becton 
dickinson, San Jose, CA, uSA).
Determination of absolute number  
of CD3+CD4+ cells
Whole peripheral blood samples (25 µl) were in-
cubated in truCount tubes (bd biosciences, bd bio-
sciences, San Jose, CA, uSA) with the following 
mono clonal antibodies: anti-Cd3-fitC, anti-Cd8- 
-Pe, anti-Cd45-PerCP and anti-Cd4-APC (bd 
multitest tm, bd biosciences, bd biosciences, San 
Jose, CA, uSA) for 30 minutes at 4 °C. Then the 
 samples were treated with 250 µl of fACS lysing 
Solution (bd biosciences, San Jose, CA, uSA) and 
after erythrocyte lysis, 10,000 of Cd3+Cd4+ cells with 
beads was acquired on a fACSCanto flow cytometer 
using fACSdiva software. The absolute numbers of 
Cd3+Cd4+ and Cd3+Cd8+ lymphocytes were calcu-
Fig. 1. Gating strategy for CD3+ CD4+ and CD3+CD8+ T cell identification in peripheral blood of colorectal cancer 
patients and healthy individuals.
Fig. 2. Gating strategy for CD4+ Foxp3+ Tregs and CD4+ IL-17+ Th17 cell identification in peripheral blood  
of colorectal cancer patients and healthy individuals.
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lated on the basis of beads and lymphocyte counts, 
 according to the formula below:
[(number of events in region containing Cd3+Cd4+ 
or Cd3+Cd8+ cells) / (number of events in absolute 
count bead region)] x [(number of beads per test) / 
(test volume)] = absolute number of Cd3+Cd4+ or 
Cd3+Cd8+ cells.
Determination of Treg and Th17 cell count
for tregs and Th17 cell analysis, PbmC were 
stained using Th17/treg human Phenotypic Kit (bd 
Pharmingentm, Canada) with the following mAbs: 
anti-Cd4-PerCP, anti-il-17A-Pe and antifoxp3-
APC, according to the manufacturer’s instructions. in 
parallel, a control sample was prepared to determine 
nonspecific cell binding of antibodies (isotype con-
trol). Samples were analyzed in fACSCanto flow cy-
tometer using fACSdiva software. The absolute num-
bers of treg cells were calculated on the basis of the 
Cd4+foxp3+, whereas Th17 cells were calculated as 
Cd4+il-17A+cells both as percentage of Cd4+ and 
absolute number of Cd3+Cd4+ cells. gating strategies 
are presented in figures 1 and 2.
Statistical analysis and ethical consideration
All data were analyzed with Statistica version 13.0 
Pl (StatSoft inc., tulsa, OK, uSA). The results were 
expressed as mean and standard deviation (Sd) and 
median. The χ2-test of independence was used to eval-
uate categorical variables. The Shapiro-Wilk test was 
used to check for normal distribution of data and the 
Student’s t test was used for normally distributed 
quantitative data. for non-normally distributed quan-
titative variables, the mann-Whitney U test was used. 
The level of statistical significance was set at p<0.05.
All procedures were performed in accordance with 
ethical standards of the 1964 declaration of helsinki 
and its later amendments (fortaleza 2013). The study 
was approved by the local ethics Committee. each 
patient signed an informed consent prior to inclusion 
in the study.
Results
fourteen patients were eventually included in the 
analysis. Patient characteristics are presented in table 
1. Preoperative counts of Cd4+, Cd8+ and tregs were 
similar in the cancer group and healthy controls 
(p=0.78, p=0.98 and p=0.94, respectively). Only Th17 
count was significantly higher in healthy controls than 
in cancer group (p=0.001) (table 2).
All patients had colorectal cancer confirmed on 
postoperative pathological examination. There were no 
statistical differences in tumor staging and immune 
cell count (Cd4+ p=0.92; Cd8+ p=0.96; Th17 p=0.42; 
treg p=0.95). no statistical significance was found re-
garding local recurrence at 1-year observation (Cd4+ 
p=0.62; Cd8+ p=0.72; Th17 p=0.25; treg p=0.72).
Table 2. Baseline number of immune cells in cancer group 
and control group
Cell type Control group Cancer group p value
Cd4+ 672 (247-975) 818 (150-1491) 0.78
Cd8+ 320 (120-611) 336 (49-998) 0.98
t reg 47.8  (14.5-73.0)
47.16  
(12.33-109.72) 0.84
Th 17 1.72 (0.74-5.28) 0.17 (0-4.47) 0.001
Table 1. Patient characteristics
general characteristics
Age (years) 66 (38-80)
Weight (kg) 73.5 (55-97)
height (cm) 165 (150-185)
length of stay (days) 6 (3-11)
morbidity 2
1-year recurrence 4
tumor localization
localization number of patients
Cecum 4
Ascending colon 1
transverse colon 0
descending colon 1
Sigmoid colon 2
Sigmoid rectal junction 6
tumor stage
Stage number of patients
i 2
iiA 9
iiib 2
iiiC 1
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There were significant differences in immune cell 
levels before and after the surgery. We observed re-
duced counts of Cd4+, Cd8+, tregs and total lym-
phocyte (p=0.002, p=0.01, p=0.008 and p=0.001, re-
spectively). We observed an increase in total WbC and 
Th17 cell count; however, Th17 lymphocytes did not 
reach statistical significance (p=0.01 and p=0.5, re-
spectively). The results are summarized in table 3.
Discussion
in our study, we found that cancer patients had a 
significantly lower level of Th17 lymphocytes than 
healthy controls. however, many authors report in-
creased levels of Th17 cells in colorectal cancer pa-
tients7,8. On the contrary, ling et al. obtained results 
similar to ours. not only were the levels of Th17 cells 
higher in healthy controls than in colorectal cancer pa-
tients, but also the number of Th17 cells correlated in-
versely with colorectal cancer stage9. Although Th17 
lymphocytes are believed to enhance anti-tumor im-
munity, they may induce adverse reaction10. Th17 cells, 
as well as tregs, accumulate in premetastatic niche, 
where they produce pro-tumorigenic factors such as 
vegf-A11. moreover, Amicarella et al. report that 
Th17 cells may secrete pro- and anti-tumorigenic fac-
tors, depending on their localization, thus the final role 
of Th17 cells requires further investigation12. lee et al. 
report that higher levels of Th17 might be useful as 
markers of lymph node invasion13. in our group, only 
two patients had lymph node invasion, thus it was too 
small to verify this hypothesis.
Surgical removal of the tumor changed the compo-
sition of immune cells. We observed a significant in-
crease in Th17 cell count, in comparison with the fig-
ure recorded in healthy controls. All of our patients 
received minimally invasive approach, thus their im-
mune system might have been less affected. however, 
ling et al. obtained similar results, i.e. colorectal cancer 
resection caused Th17 lymphocyte count elevation9. 
An interesting study by Zhang et al. investigated the 
number of tregs and nK cells in patients undergoing 
video-assisted thoracoscopic surgery (vAtS) lobecto-
my or classic thoracotomy due to non-small cell lung 
carcinoma. in their research, the number of tregs was 
lower after than before the surgery in both groups. 
however, at 90-day follow up, patients having under-
gone vAtS lobectomy had lower tregs count than 
thoracotomy group14. This may favor minimally inva-
sive approach in cancer surgery. All our patients were 
operated with minimally invasive techniques, which 
are believed to cause less trauma to the patient. how-
ever, large studies including meta-analyses found no 
difference in long-term oncologic outcomes compar-
ing open surgery and laparoscopic approach15-17. A 
small number of researches comparing open and lapa-
roscopic surgery may stimulate novel study designs for 
perioperative immunoregulation.
removal of the tumor also caused drop in the 
number of foxp3 regulatory lymphocytes. however, 
their number after the surgery was lower than in 
healthy controls. The role of tregs remains controver-
sial. it is worth mentioning that we also found an in-
creased number of foxp3 cells in tumor microenviron-
ment in early stages of colorectal carcinoma develop-
ment, such as adenoma with high-grade dysplasia18. 
Waniczek et al. identified intense tregs infiltration in 
tumor stroma as an independent factor of shorter dis-
ease-free survival and overall survival19. As mentioned 
before, lymphocyte infiltration in tumor environment 
rich in foxp3 lymphocytes is a negative prognostic 
factor in many neoplasms. On the contrary, a recent 
meta-analysis including 3811 patients assessed the 
Table 3. Number of immune cells before and after surgery
Cell type number before surgery 
(median, range)
number after surgery 
(cells/ul, median, range)
p value
Cd4+ (cells/ul) 818 (150-1491) 321 (160-986) 0.002
Cd8+ (cells/ul) 336 (49-998) 260 (24-992) 0.01
treg (cells/ul) 47.16 (12.33-109.72) 27.1 (9.44-123.25) 0.008
Th17 (cells/ul) 0.17 (0-4.47) 0.33 (0-10) 0.5
WbC (10^3/mm3) 4.7 (2.4-10.3) 8.1 (4.9-13.3) 0.01
lymphocyte count (10^3/mm3) 1.35 (0.4-3.2) 1.1 (0.3-2.3) 0.01
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prognostic value of foxp3 lymphocytes in colorectal 
cancer microenvironment. tregs infiltration in tumor 
stroma and epithelium was found to correlate posi-
tively with 1-, 3-, 5- and 10-year survival. however, 
this finding did not refer to disease-free survival20. The 
study was also focused on tumor microenvironment, 
and tregs number in peripheral blood was not as-
sessed.
We are also aware that our study had some limita-
tions. firstly, study group had only 14 patients. more 
cases would significantly increase the study value and 
statistical significance of our results. long-term con-
trol of lymphocyte subtypes would also be valuable, 
however, most of our patients underwent adjuvant 
chemotherapy or radiotherapy, which severely inter-
feres with immune cell composition. nevertheless, 
there are some data supporting the hypothesis that ra-
diotherapy does not affect tregs population21.
Conclusion
Surgical intervention caused changes in all lym-
phocyte subpopulations investigated in patients un-
dergoing surgery for colorectal cancer. however, it 
seemed to be the effect of perioperative trauma. Ad-
ditional studies are needed to investigate the impact of 
surgical intervention on lymphocyte subpopulations.
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Sažetak
PeriOPerACiJSKe PrOmJene SubPOPulACiJA limfOCitA  
u bOleSniKA OPerirAnih ZbOg KOlOreKtAlnOg KArCinOmA
M. Rubinkiewicz, I. Siemińska, P. Małczak, P. Major, J. Baran, A. Budzyński i M. Pędziwiatr
Kirurški zahvat ima golem učinak na ravnotežu imunog sustava. međutim, malo se zna o perioperacijskim promjenama 
u subpopulacijama t regulatornih i Th17 limfocita u bolesnika podvrgnutih resekciji kolorektuma. u istraživanje su bili 
uključeni bolesnici s resektabilnim karcinomom kolona. uzorci krvi prikupljeni su dva puta: prije zahvata i dva dana nakon 
operacije. uključena je bila i kontrolna skupina sastavljena od mladih i zdravih osoba. Subpopulacije limfocita analizirane su 
protočnom citometrijom. istraživane su sljedeće subpopulacije: ukupan broj limfocita, Cd4+, Cd8+, t regulatorni foxp3+ 
(tregs), Th17 i bijela krvna slika. utvrđene su značajne razlike u razinama imuno stanica prije i nakon operacije. Snižene 
razine zabilježene su za Cd4+, Cd8+, tregs i ukupni broj limfocita (p=0,002, p=0,01, p=0,008 odnosno p=0,001). Povišenje 
je zapaženo za bijelu krvnu sliku i Th17 stanice, međutim, Th17 limfociti nisu postigli statističku značajnost (p=0,01 odnosno 
p=0,5). Zaključujemo da je kirurški zahvat uzrokovao promjene u svim istraživanim subpopulacijama limfocita kod bolesni-
ka podvrgnutih operaciji kolorektalnog karcinoma. međutim, čini se da je to bio učinak perioperacijske traume. Potrebna su 
daljnja istraživanja kako bi se ispitao utjecaj kirurškog zahvata na subpopulacije limfocita.
Ključne riječi: Subpopulacije limfocita; T-limfociti, regulacijski; Th17 stanice; Broj limfocita; Kolorektalna kirurgija
